By 2025, GLP-1 injections have become a "super target" in the global pharmaceutical industry
Its care delivered with depth, integrity, and experience, right here in the heart of Newport Beach
The volume is large, which means drawing higher doses requires multiple syringe loads
Drug-specific monitoring schedule | Drug | Monitoring parameter | Timing after GLP-1 start | |---|---|---| | Warfarin | INR | 2 weeks, 4 weeks, then per standard | | Levothyroxine | TSH | 6 to 8 weeks | | Cyclosporine/tacrolimus | Trough level | Weekly for first 8 weeks | | Oral contraceptive | Add barrier method | For first 4+ weeks per Ozempic label | | Digoxin | Serum digoxin, ECG if symptomatic | 4 weeks | | Lithium | Serum lithium | 2 to 4 weeks, especially if nausea reduces fluid intake | What the Clinical Trial Data Actually Show Most large GLP-1 outcome trials were not designed to measure drug-drug interactions, but pharmacokinetic sub-studies and post-marketing data fill some gaps
1 The incretin effect was termed when researchers noted that individuals had a greater secretion of insulin following an oral glucose challenge as opposed to IV glucose administration